332 related articles for article (PubMed ID: 2791500)
21. In vitro activity of lomefloxacin as compared with ciprofloxacin.
Inderlied CB; Lancero MG; Bermudez LM; Young LS
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):17S-20S. PubMed ID: 2791493
[TBL] [Abstract][Full Text] [Related]
22. In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.
Bongaerts GP; Hoogkamp-Korstanje JA
Antimicrob Agents Chemother; 1993 Sep; 37(9):2017-9. PubMed ID: 8239624
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria.
Sedlock DM; Dobson RA; Deuel DM; Lesher GY; Rake JB
Antimicrob Agents Chemother; 1990 Apr; 34(4):568-75. PubMed ID: 2344163
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
Qadri SM; Lee GC; Ellis ME
Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
Hardy DJ
Am J Med; 1991 Dec; 91(6A):19S-23S. PubMed ID: 1662890
[TBL] [Abstract][Full Text] [Related]
26. Bactericidal activity of lomefloxacin SC 47111 (NY-198) and ciprofloxacin against selected pathogens.
Stratton CW; Weeks LS
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):29S-34S. PubMed ID: 2791495
[TBL] [Abstract][Full Text] [Related]
27. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of sparfloxacin compared with those of five other quinolones.
Cantón E; Pemán J; Jimenez MT; Ramón MS; Gobernado M
Antimicrob Agents Chemother; 1992 Mar; 36(3):558-65. PubMed ID: 1320362
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.
Chin NX; Novelli A; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):656-62. PubMed ID: 3164987
[TBL] [Abstract][Full Text] [Related]
30. In vitro antibacterial activity of Q-35, a new fluoroquinolone.
Ito T; Otsuki M; Nishino T
Antimicrob Agents Chemother; 1992 Aug; 36(8):1708-14. PubMed ID: 1329626
[TBL] [Abstract][Full Text] [Related]
31. In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone.
Jones RN; Barry AL
Antimicrob Agents Chemother; 1990 Feb; 34(2):306-13. PubMed ID: 2327779
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.
Hosaka M; Yasue T; Fukuda H; Tomizawa H; Aoyama H; Hirai K
Antimicrob Agents Chemother; 1992 Oct; 36(10):2108-17. PubMed ID: 1332587
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial activity of CS-940, a new trifluorinated quinolone.
Biedenbach DJ; Sutton LD; Jones RN
Antimicrob Agents Chemother; 1995 Oct; 39(10):2325-30. PubMed ID: 8619590
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of CP-74,667. A new fluoroquinolone compared with other quinolones.
Gu JW; Fang W; Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1992; 15(7):613-20. PubMed ID: 1330421
[TBL] [Abstract][Full Text] [Related]
35. In-vitro activity of lomefloxacin (SC-47111) and other quinolones.
Sun ZM; Maskell JP; Sehgal SC; Williams JD
Infection; 1989; 17(3):165-7. PubMed ID: 2737760
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of AT-4140 against clinical bacterial isolates.
Kojima T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1989 Nov; 33(11):1980-8. PubMed ID: 2558617
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
Sato K; Hoshino K; Tanaka M; Hayakawa I; Osada Y
Antimicrob Agents Chemother; 1992 Jul; 36(7):1491-8. PubMed ID: 1324647
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antimicrobial, against clinical isolates of common pathogens.
Sonstein SA; Dahlgren J
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):21S-28S. PubMed ID: 2791494
[TBL] [Abstract][Full Text] [Related]
39. In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent.
Cooper MA; Andrews JM; Ashby JP; Matthews RS; Wise R
J Antimicrob Chemother; 1990 Nov; 26(5):667-76. PubMed ID: 2079449
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo antibacterial efficacies of CFC-222, a new fluoroquinolone.
Kim JH; Kang JA; Kim YG; Kim JW; Lee JH; Choi EC; Kim BK
Antimicrob Agents Chemother; 1997 Oct; 41(10):2209-13. PubMed ID: 9333049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
